Haven Capital Group, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 2055804 CAMARILLO, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$344,908

-$35,572 QoQ

Shares Held

2,730

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#1,580

of 2,266 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Haven Capital Group, Inc. holds $6,551,690 across 4 Drug Manufacturers - General names. GILD ranks #2 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	22,119	$5,566,025
2	GILD	Gilead Sciences, Inc. This page	2,730	$344,908
3	BMY	Bristol Myers Squibb Co	5,958	$343,299
4	LLY	ELI LILLY & Co	248	$297,458

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$344,908	2,730	0.0%	Shares	Sole	2026-08-14
2026-03-31	$380,480	2,730	0.0%	Shares	Sole	2026-04-20
2025-12-31	$335,080	2,730	-31.5%	Shares	Defined	2026-01-15
2025-09-30	$442,557	3,987	0.0%	Shares	Defined	2025-11-12
2025-06-30	$442,038	3,987	-7.5%	Shares	Defined	2025-08-14
2025-03-31	$482,935	4,310	-6.8%	Shares	Defined	2025-05-15
2024-12-31	$427,211	4,625	—	Shares	Sole	2025-02-10
No filing history on record for this holder in this stock.